Drawing for AVARUS

USPTO serial 79201898

AVARUS

Reviewed by CopyMark Law Group

Reg. 5477598Status 707Registered
Filing date
Status date
Registration date
May 29, 2018
Examiner
O'BRIEN, JENNIFER LYNN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with AVARUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical and medical preparations for treating wounds; pharmaceutical and medical preparations for wound care; plasters for medical purposes; materials for medical dressings, namely, gauze, non-woven fabrics, wadding, absorbent foams and absorbent pads; ] medical dressings; surgical dressings; wound dressings; occlusive wound dressings; adhesive wound dressings; [ wound healing preparations in the nature of pharmaceutical preparations for wounds; gauzes for medical and surgical use; ] wound healing dressings; [ sanitary preparations for medical purposes; ] medical dressings in the nature of absorbent foam dressings, antimicrobial absorbent foam dressings, non-woven dressings and antimicrobial non-woven dressings, coverings in the nature of medical and wound dressings, namely, bandages for dressings, antimicrobial gels as a sterilised dressing, silicone wound contact layers, and skin protectant barrier lotions impregnated on foam or tissue dressings; [ medical pads in the nature of medical and wound dressings impregnated with an antimicrobial, antibacterial or antiseptic treatment; ] antimicrobial preparations for preventing bacteria, antibacterial substances for medical purposes and antiseptic preparations; medical and wound dressings impregnated with antimicrobial, antibacterial and antiseptic preparations for wounds, burns and surgery; [ disinfectant medical dressings for wounds, burns and surgery; ] sterilized dressings [ ; self-adhesive dressings and patches for medical purposes in the nature of medical and wound dressings; transdermal patches for use in the treatment of wounds; haemostatic wound dressings ]ACTIVE—
010[ Surgical apparatus and instruments for medical and veterinary use; medical devices for use in the treatment of wounds, namely, chronic wounds, surgical wounds, venous leg ulcers, diabetic foot ulcers, burns, pressure sores and for use in reducing infections; haemostatic devices in the nature of haemostats; wound treating equipment, namely, medical devices for closing wounds; catheter skin anchor apparatus and instruments in the nature of medical devices for placing and securing catheters; medical devices for placing and securing catheters; catheter parts and fittings in the nature of protective guards for catheters; supportive bandages for surgical purposes; elastic compression bandages for surgical purposes; catheters; catheters for medical use; medicinal catheters; catheter parts and fittings therefor ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 16, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Feb 25, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 25, 2026INPCINVALIDATION PROCESSED—
Sep 26, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 10, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 6, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 6, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 6, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Dec 30, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 29, 2024ES71TEAS SECTION 71 RECEIVED—
May 29, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 28, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 5, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 5, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 9, 2018GPNXNOTIFICATION PROCESSED BY IB—
Feb 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 3, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 3, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 16, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 2, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 2, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 2, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2017RFNPREFUSAL PROCESSED BY IB—
Mar 8, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 8, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2017DOCKASSIGNED TO EXAMINER—
Feb 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance